Menu
Back to Journals » Therapeutics and Clinical Risk Management » Volume 16
Review
Evaluating the Safety, Efficacy, and Therapeutic Potential of Momelotinib in the Treatment of Intermediate/High-Risk Myelofibrosis: Evidence to Date
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 5,900 | Dovepress* | 5,022+ | 732 | 5,754 | |
| PubMed Central* | 878 | 234 | 1,112 | ||
| Totals | 5,900 | 966 | 6,866 | ||
| *Since 25 September 2020 | |||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 28 | 0 | 0 | 0 | 1 | 27 |
View citations on PubMed Central and Google Scholar